Market Place
Sourcing Support
Mazumdar-Shaw Rates Global Sites Best for PLI & RDI Incentives
08 Apr 2026 //
PHARMABIZ
With Sights On Huge Gains, Biocon To Scale Up AI Focus
08 Apr 2026 //
ECONOMICTIMES
Biocon Launches Bosaya and Aukelso Biosimilars in US
07 Apr 2026 //
PHARMIWEB
With Sights On Huge Gains, Biocon To Scale Up AI Focus
07 Apr 2026 //
ECONOMICTIMES
Biocon Rolls Out Two Biosimilars In US Market
07 Apr 2026 //
ECONOMICTIMES
Biocon Renames Irish Subsidiary To Biocon Biologics Ireland
06 Apr 2026 //
INDPHARMAPOST
Biocon`s Shaw: Budget Boosts India`s Health, Innovation
01 Feb 2026 //
ECONOMICTIMES
Biocon Biologics Gets Credit Boost From S&P, Outlook Stable
30 Jan 2026 //
INDPHARMAPOST
Biocon Launches Liraglutide for Diabetes, Obesity in India
15 Dec 2025 //
EXPRESSPHARMA
USC India Honors Kiran Mazumdar-Shaw with Top Business Award
10 Dec 2025 //
EXPRESSPHARMA
Biocon To Merge Biocon Biologics In $5.5 Billion Deal
06 Dec 2025 //
REUTERS
Biocon Biologics Settles With Amgen For Denosumab Biosimilars
02 Dec 2025 //
EXPRESSPHARMA
Biocon Stands Out Globally As Biosimilars Leader: Kiran
21 Nov 2025 //
ECONOMICTIMES
Biocon Considers Merging Biocon Biologics in $4.5 Billion Deal
13 Nov 2025 //
ECONOMICTIMES
Biocon Opens First US Manufacturing Facility in Cranbury, NJ
10 Sep 2025 //
PR NEWSWIRE
Biocon Q1 FY26 PAT Drops 95% to Rs. 31.4 Cr
08 Aug 2025 //
INDPHARMAPOST
Deepali Appointed as Biocon` Corporate Communications Head
23 Jul 2025 //
EXPRESSPHARMA
Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr
14 May 2025 //
INDPHARMAPOST
Biocon accused of IP theft to create cancer biotech Bicara
24 Oct 2024 //
FIERCE BIOTECH
Biocon Report Explores Pathways To Increase Biosimilar Adoption
09 Oct 2024 //
EXPRESSPHARMA
Biocon Settles With Janssen To Sell Biosimilars In Multiple Regions
29 Aug 2024 //
CONTRACT PHARMA
US FDA approves two biosimilars for blockbuster eye drug Eylea
21 May 2024 //
REUTERS
Acceleration of biosimilar business, debt reduction priorties in FY25: Biocon
18 May 2024 //
ECONOMICTIMES
Biocon to obtain approval for diabetes drug, Liraglutide in UK
28 Mar 2024 //
INDINPHARMAPOST
India`s Biocon posts profit on biosimilar boost, divestment gains
08 Feb 2024 //
REUTERS
Biocon Announces Positive CHMP Opinion for YESAFILI, Biosimilar Aflibercept
25 Jul 2023 //
PR NEWSWIRE
Govt grants sanction to prosecute joint drugs controller S Eswara Reddy
23 Jul 2023 //
ECONOMIC TIMES
Biocon Biologics takes over Viatris` biosimilar biz in over 70 countries
05 Jul 2023 //
ECONOMIC TIMES
India`s Biocon Biologics launches biosimilar for AbbVie`s Humira in US
04 Jul 2023 //
ECONOMIC TIMES
Biocon may raise additional equity of $300 million in FY24 to pare debt
25 May 2023 //
ECONOMIC TIMES
CCI clears Edelweiss-Biocon Biologics deal
10 May 2023 //
EXPRESS PHARMA
Biocon Biologics facility gets EU GMP certification for Bevacizumab
29 Apr 2023 //
HEALTH ET
Serum Institute doubles its stake in Biocon Biologics to $300M
25 Apr 2023 //
FIERCE PHARMA
Biocon raises $129 million from Kotak to fund biosimilars deal
22 Feb 2023 //
ECONOMIC TIMES
Biocon Biologics has comprehensive plan to integrate Viatris business
16 Feb 2023 //
ECONOMIC TIMES
